ACRS icon

Aclaris Therapeutics
ACRS

Overview Fund Activity

110 hedge funds and large institutions have $707M invested in Aclaris Therapeutics in 2017 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 38 increasing their positions, 32 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
110
Holders Change
+10
Holders Change %
+10%
% of All Funds
2.74%
Holding in Top 10
5
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-37.5%
% of All Funds
0.12%
New
32
Increased
38
Reduced
32
Closed
16
Calls
$3.28M
Puts
–
Net Calls
+$3.28M
Net Calls Change
+$3.28M

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$49.3M
2
PC
2
Polar Capital
United Kingdom
$29M
3
BlackRock
3
BlackRock
New York
$23.3M
4
Point72 Asset Management
4
Point72 Asset Management
Connecticut
$13.7M
5
Loomis, Sayles & Company
5
Loomis, Sayles & Company
Massachusetts
$11.9M

Top Sellers

1
SMV
1
Sofinnova Management VIII
California
$45.9M
2
RSCM
2
Rock Springs Capital Management
Maryland
$20.1M
3
VC
3
Vivo Capital
California
$85.2M
4
Marshall Wace
4
Marshall Wace
United Kingdom
$0
5
Franklin Resources
5
Franklin Resources
California
$37.5M
Name Holding Trade Value Shares
Change 		Shares
Change %
TI
126
Turner Investments
Pennsylvania
– -$20K -750 Closed
2 3 4 5
6